CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF1α

Xi Tian, Minh Nguyen, Henry P. Foote, Joseph M. Caster, Kyle C. Roche, Christian G. Peters, Pauline Wu, Lata Jayaraman, Edward G. Garmey, Joel E. Tepper, Scott Eliasof, Andrew Z. Wang

Research output: Contribution to journalArticlepeer-review

59 Scopus citations

Fingerprint

Dive into the research topics of 'CRLX101, a nanoparticle-drug conjugate containing camptothecin, improves rectal cancer chemoradiotherapy by inhibiting DNA repair and HIF1α'. Together they form a unique fingerprint.

Medicine & Life Sciences